Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the drug dutasteride increases expression of
genes that slow the growth of prostate cancer during treatment with intermittent androgen
ablation therapy (hormone therapy).
Phase:
Phase 2
Details
Lead Sponsor:
NorthShore University HealthSystem NorthShore University HealthSystem Research Institute